Septerna (SEPN) Long-Term Investments (2024 - 2026)
Septerna's (SEPN) quarterly Long-Term Investments came in at $174.7 million in Q1 2026, up 180.66% year-on-year from $62.2 million in Q1 2025, and up 10.87% quarter-over-quarter from $157.6 million in Q4 2025.
Septerna (SEPN) Long-Term Investments (2024 - 2026) Analysis & Trends
Septerna's Long-Term Investments history runs 3 years deep, the most recent figure standing at $174.7 million for Q1 2026.
- On a quarterly basis, Long-Term Investments rose 180.66% year-over-year to $174.7 million in Q1 2026; TTM through Mar 2026 was $174.7 million, a 180.66% increase from a year earlier, with the FY2025 full-year figure at $157.6 million, up 125.53% from the prior year.
- Long-Term Investments rose to $174.7 million in Q1 2026 per SEPN's latest filing, from $157.6 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $174.7 million in Q1 2026 and bottomed at $7.0 million in Q3 2024.
- The 3-year median for Long-Term Investments is $69.9 million (2024), against an average of $87.3 million.
- Biggest YoY gain for Long-Term Investments was 1149.63% in 2025; the steepest drop was 125.53% in 2025.
- Year by year, Long-Term Investments stood at $69.9 million in 2024, then surged by 125.53% to $157.6 million in 2025, then gained by 10.87% to $174.7 million in 2026.
- Per Business Quant, the three latest SEPN Long-Term Investments figures stand at $174.7 million (Q1 2026), $157.6 million (Q4 2025), and $87.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 174.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174.69 Mn |
| Dec 31, 2025 | 157.57 Mn |
| Sep 30, 2025 | 87.21 Mn |
| Jun 30, 2025 | 52.63 Mn |
| Mar 31, 2025 | 62.24 Mn |
| Dec 31, 2024 | 69.87 Mn |
| Sep 30, 2024 | 6.98 Mn |